Monin Modithis is the requirement doc
Sign in to leave a comment
percentile among age-matched pediatric cohort (n = 1,204)
94% reliability score
Narrative synthesis of assessment performance and behavioral context
This assessment evaluated depressive symptom severity across the nine PHQ-9 item domains, including mood, interest, sleep, appetite, concentration, and self-harm risk. Scoring draws on standardized clinical instruments combined with 14 days of behavioral and activity signal synchronized from the NEURO World mobile application.
Patient scored in the moderate range on the PHQ-9, consistent with self-reported low mood and reduced interest captured during intake.
The self-harm risk item indicated no current thoughts of self-harm, consistent with the patient’s safety screening at intake.
Responses to the interest/pleasure and energy items reflected persistent anhedonia and fatigue over the past two weeks, aligning with DSM-5 depressive criteria.
Wearable-derived sleep and activity metrics over the prior 14 days showed no clinically significant disruption correlating with symptom fluctuation.
Domain-level sub-scores, category breakdowns, and response patterns from the assessment session.
Patient demonstrates strong sustained attention with only minor variability during divided-attention tasks. Response latency remained stable across trial blocks.
Wearable-derived activity signals show improving consistency week over week; task persistence remains the primary area for continued monitoring.
Mood self-reports are stable across the assessment window with adaptive coping strategies reported in the majority of stress-related prompts.
Inhibitory control scored below the expected range, correlating with clinician-observed impulsivity during task-switching segments.
Processing speed remains a relative strength, with reaction times consistently within the top quartile for the patient’s age cohort.
Backward span performance shows a decline from baseline, suggesting increased load sensitivity under sequential recall demands.
Progress across prior neuro assessments for this patient
Latest assessment completed Aug 7, 2026 — score of 83 places this result in the 76th percentile relative to prior sessions.
Generated by neuro's clinical AI layer from this assessment, wearable signals, and behavioral data — prioritized by urgency with evidence backing each finding.
This patient's PHQ-9 composite score rose from 12 to 19 over the past 30 days, moving from “moderate” to “moderately severe” range. The pattern correlates with declining wearable sleep-efficiency readings recorded in the same window.
Schedule a psychiatric follow-up within 5 business days and log outreach in the care timeline.
Response pattern on PHQ-9 item 9 indicates an elevated risk marker that warrants same-day clinical review, per the standard care pathway for self-harm screening flags.
Average nightly sleep duration dropped from 6h 40m to 5h 05m across two weeks, tracking closely against daily mood-log entries and a reduced average step count.
Completion rate for assigned behavioral activation exercises fell to 38% this cycle, down from 71% the prior cycle, suggesting possible motivational barriers worth exploring in session.
GAD-7 score has held steady at 7–8 across the last three assessments, indicating persistent mild anxiety symptoms with no significant escalation.
Self-reported adherence logs and reminder-app confirmations show 94% consistency over the past month, with no clustered missed-dose events.
AI-generated insights assist clinical decision-making. Always apply professional clinical judgment when interpreting these recommendations.
Choose an action based on this assessment’s results and clinical insights.
Queue a related assessment to track progress on flagged domains.
Assign a clinical or care-coordination task tied to these results.
Reflect this assessment’s findings in the patient’s active care plan.
Download a shareable copy of this assessment for records or referrals.
Evidence-based recommendations generated from patient wearable data, clinical assessments, and AI insight synthesis. Review, prioritize, and act on guidance tailored to each patient's current care plan.
Select a recommendation above to enable these actions.
No comments yet. Be the first!